Caspofungin Study for Fungal Infections in Adults in Critical Care Settings

NCT00095316 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

1200

Enrollment

NIH

Sponsor class

Conditions

Candidiasis

Interventions

DRUG: Caspofungin
OTHER: Placebo

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)